circulatory support are scant" (9) . Identification of weaknesses is the first step. Next, cardiovascular disease fellows should be trained to become leaders in the field of advanced HF specific to ACHD patients.
One obvious challenge is that under the current 1 year of advanced HF/transplant training, there is no required ACHD or pediatric HF training. Currently, the general cardiovascular disease (CVD) fellowship requires only a brief exposure to ACHD, which is clearly insufficient. How can we expect improvement in HF and transplantation outcomes in these patients if the trainee's first exposure to a failing Dr. Menachem has raised the important concern of how to best prepare for complex yet foreseeable issues that plague adults with CHD, yet involve expertise beyond the scope of standard adult CHD training. These may include advanced heart failure therapies and transplantation, arrhythmia and hemodynamic interventions, specialized imaging, high-risk pregnancy, pulmonary hypertension, genetic counseling, and end-of-life care. Although each regional and supraregional adult CHD center must grapple 
